iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $41K invested in iPath Pure Beta Lead ETN in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
141% more capital invested
Capital invested by funds: $17K → $41K (+$24K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$22.6K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
1
UBS
Zurich,
Switzerland
| $35K | +$22.6K | +600 | +188% |
|
2
Wells Fargo
San Francisco,
California
| $6K | – | – | – |
|
LEDD Hedge Fund Activity: Q2 2014 in Review
2 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q2 2014, worth a combined $41K — up 141% from $17K a quarter earlier.
Fund positioning in LEDD was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS, adding an estimated $22.6K.
- 2 institutional investors held iPath Pure Beta Lead ETN (LEDD) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $41K of iPath Pure Beta Lead ETN stock for Q2 2014, up 141% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Lead ETN positions in Q2 2014 and 0 closed out.
- The largest iPath Pure Beta Lead ETN buyer in Q2 2014 was UBS, an estimated $22.6K added.
Based on aggregated 13F filings for Q2 2014.